LOSINGMOREWITHTIME Trademark

Trademark Overview

On Monday, September 28, 2020, a trademark application was filed for LOSINGMOREWITHTIME with the United States Patent and Trademark Office. The USPTO has given the LOSINGMOREWITHTIME trademark a serial number of 90217527. The federal status of this trademark filing is REGISTERED as of Tuesday, May 27, 2025. This trademark is owned by Aurinia Pharmaceuticals Inc.. The LOSINGMOREWITHTIME trademark is filed in the Advertising, Business and Retail Services, Education & Entertainment Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Educational services, namely, organizing, conducting and presentation of seminars in the field of lupus nephritis for the public, medical professionals, and patients

Promoting public awareness of lupus nephritis

Providing medical information on lupus nephritis to the public, medical professionals, and patients

Research and development on lupus nephritis; scientific research, namely, conducting clinical trials for others in the field of lupus nephritis; research and development of medicinals and pharmaceuticals
losingmorewithtime

General Information

Serial Number90217527
Word MarkLOSINGMOREWITHTIME
Filing DateMonday, September 28, 2020
Status700 - REGISTERED
Status DateTuesday, May 27, 2025
Registration Number7805901
Registration DateTuesday, May 27, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 8, 2025

Trademark Statements

Goods and ServicesEducational services, namely, organizing, conducting and presentation of seminars in the field of lupus nephritis for the public, medical professionals, and patients
Pseudo MarkLOSING MORE WITH TIME
Goods and ServicesPromoting public awareness of lupus nephritis
Goods and ServicesProviding medical information on lupus nephritis to the public, medical professionals, and patients
Goods and ServicesResearch and development on lupus nephritis; scientific research, namely, conducting clinical trials for others in the field of lupus nephritis; research and development of medicinals and pharmaceuticals

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, August 3, 2021
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateTuesday, November 10, 2020
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, November 10, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 3, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAurinia Pharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type11 - Company
AddressVictoria, BC V8Z7X8
CA
Party NameAurinia Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type11 - Company
AddressVictoria, BC V8Z7X8
CA
Party NameAurinia Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressVictoria, BC V8Z7X8
CA

Trademark Events

Event DateEvent Description
Thursday, October 1, 2020NEW APPLICATION ENTERED
Tuesday, November 10, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 19, 2021ASSIGNED TO EXAMINER
Tuesday, February 23, 2021NON-FINAL ACTION WRITTEN
Tuesday, February 23, 2021NON-FINAL ACTION E-MAILED
Tuesday, February 23, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 2, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 2, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 3, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 13, 2021SUSPENSION LETTER WRITTEN
Monday, September 13, 2021LETTER OF SUSPENSION E-MAILED
Monday, September 13, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, May 6, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, June 7, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, June 27, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Saturday, August 13, 2022SUSPENSION INQUIRY WRITTEN
Saturday, August 13, 2022NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Saturday, August 13, 2022INQUIRY TO SUSPENSION E-MAILED
Monday, February 13, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, May 22, 2023ASSIGNED TO LIE
Monday, May 22, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 22, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 30, 2023SUSPENSION LETTER WRITTEN
Tuesday, May 30, 2023LETTER OF SUSPENSION E-MAILED
Tuesday, May 30, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, January 10, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, January 26, 2024SUSPENSION INQUIRY WRITTEN
Friday, January 26, 2024INQUIRY TO SUSPENSION E-MAILED
Friday, January 26, 2024NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, April 16, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, April 17, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 17, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 3, 2024LETTER OF SUSPENSION E-MAILED
Friday, May 3, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, May 3, 2024SUSPENSION LETTER WRITTEN
Wednesday, January 29, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, February 10, 2025SUSPENSION INQUIRY WRITTEN
Monday, February 10, 2025INQUIRY TO SUSPENSION E-MAILED
Tuesday, February 18, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, March 15, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 18, 2025LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 2, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 8, 2025PUBLISHED FOR OPPOSITION
Tuesday, April 8, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 27, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, May 27, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Monday, February 10, 2025NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, February 13, 2025TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, February 18, 2025TEAS/EMAIL CORRESPONDENCE ENTERED

Related Keywords

losingmorewithtime lupus nephritis medical research public patients development professionals namely conducting